Tags

Type your tag names separated by a space and hit enter

Ganglion Impar block improves neuropathic pain in coccygodynia: A preliminary report.
Neurol Neurochir Pol 2018 Sep - Oct; 52(5):612-617NN

Abstract

AIM OF THE STUDY

To define the effectiveness of ganglion Impar block in improving neuropathic pain.

MATERIALS AND METHODS

Patients who had pain around the coccyx for more than three months and did not respond to conservative treatment were included in this study. All the patients underwent fluoroscopy guided transsacrococcygeal ganglion Impar block with injecting 3 mL of 0.5% bupivacaine, 2 mL saline, and 1 mL (40 mg) of methylprednisolone. Patients were evaluated with visual analog scale (VAS) for pain, Leeds assessment of neuropathic symptoms and signs scale (LANSS) for neuropathic pain, Beck depression Inventory (BDI) for mood and Short-form 12 (SF-12) for quality of life before, 1 month 3 months and 6 months after the injection. Patients' painless sitting duration was also recorded.

RESULTS

A total of 28 patients were included in the final analyses. VAS and LANSS scores improved significantly throughout the follow-up periods. BDI scores also improved while SF-12 scores did not show significant changes. Painless sitting period of the patients' improved significantly.

CONCLUSIONS

Ganglion Impar block is effective in decreasing the neuropathic component of chronic coccygodynia. This improves painless sitting in patients but its reflections on quality of life is not clear.

Authors+Show Affiliations

Department of Physical Medicine and Rehabilitation, Division of Pain Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.Department of Physical Medicine and Rehabilitation, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey. Electronic address: ozgekenis@gmail.com.Department of Physical Medicine and Rehabilitation, Kayseri Training and Research Hospital, Kayseri, Turkey.Department of Physical Medicine and Rehabilitation, Adiyaman University Training and Research Hospital, Adiyaman, Turkey.Department of Physical Medicine and Rehabilitation, Division of Pain Medicine, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.Department of Physical Medicine and Rehabilitation, Division of Pain Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

30195465

Citation

Sencan, Savas, et al. "Ganglion Impar Block Improves Neuropathic Pain in Coccygodynia: a Preliminary Report." Neurologia I Neurochirurgia Polska, vol. 52, no. 5, 2018, pp. 612-617.
Sencan S, Kenis-Coskun O, Demir FGU, et al. Ganglion Impar block improves neuropathic pain in coccygodynia: A preliminary report. Neurol Neurochir Pol. 2018;52(5):612-617.
Sencan, S., Kenis-Coskun, O., Demir, F. G. U., Cuce, I., Ercalık, T., & Gunduz, O. H. (2018). Ganglion Impar block improves neuropathic pain in coccygodynia: A preliminary report. Neurologia I Neurochirurgia Polska, 52(5), pp. 612-617. doi:10.1016/j.pjnns.2018.08.006.
Sencan S, et al. Ganglion Impar Block Improves Neuropathic Pain in Coccygodynia: a Preliminary Report. Neurol Neurochir Pol. 2018;52(5):612-617. PubMed PMID: 30195465.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Ganglion Impar block improves neuropathic pain in coccygodynia: A preliminary report. AU - Sencan,Savas, AU - Kenis-Coskun,Ozge, AU - Demir,Fatma Gul Ulku, AU - Cuce,Isa, AU - Ercalık,Tulay, AU - Gunduz,Osman Hakan, Y1 - 2018/08/28/ PY - 2018/06/16/received PY - 2018/07/20/revised PY - 2018/08/15/accepted PY - 2018/9/10/pubmed PY - 2019/6/14/medline PY - 2018/9/10/entrez KW - Coccygodynia KW - Ganglion Impar KW - Neuropathic pain KW - Sympathetic block SP - 612 EP - 617 JF - Neurologia i neurochirurgia polska JO - Neurol. Neurochir. Pol. VL - 52 IS - 5 N2 - AIM OF THE STUDY: To define the effectiveness of ganglion Impar block in improving neuropathic pain. MATERIALS AND METHODS: Patients who had pain around the coccyx for more than three months and did not respond to conservative treatment were included in this study. All the patients underwent fluoroscopy guided transsacrococcygeal ganglion Impar block with injecting 3 mL of 0.5% bupivacaine, 2 mL saline, and 1 mL (40 mg) of methylprednisolone. Patients were evaluated with visual analog scale (VAS) for pain, Leeds assessment of neuropathic symptoms and signs scale (LANSS) for neuropathic pain, Beck depression Inventory (BDI) for mood and Short-form 12 (SF-12) for quality of life before, 1 month 3 months and 6 months after the injection. Patients' painless sitting duration was also recorded. RESULTS: A total of 28 patients were included in the final analyses. VAS and LANSS scores improved significantly throughout the follow-up periods. BDI scores also improved while SF-12 scores did not show significant changes. Painless sitting period of the patients' improved significantly. CONCLUSIONS: Ganglion Impar block is effective in decreasing the neuropathic component of chronic coccygodynia. This improves painless sitting in patients but its reflections on quality of life is not clear. SN - 0028-3843 UR - https://www.unboundmedicine.com/medline/citation/30195465/Ganglion_Impar_block_improves_neuropathic_pain_in_coccygodynia:_A_preliminary_report L2 - http://www.diseaseinfosearch.org/result/1699 DB - PRIME DP - Unbound Medicine ER -